Clinical Trials Browser

Unknown × Recurrence × Temozolomide × Clear all

NCT02761070 2023-03-08

RE-GEND

Phase 3 Unknown

Glioblastoma, Recurrence, Disease Progression

NCT00521482 2007-08-28

Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma

Phase 2 Unknown

Glioblastoma, Recurrence